Treatments
Should I Get a Second Opinion?
If you’ve been newly diagnosed with cancer, getting a second opinion can help you choose the best doctor and treatment for you. Here's why.
Why Immunotherapy Might Be Your Cancer-fighting Superhero
Imagine giving your immune system a superhero suit that’s tailored to fight your cancer. Immunotherapy teams up with your immune system to do just that. Could it be a treatment option that's right for you?
Bone Cancer Awareness Month
Daniel Jacobs is a 2-time middleweight world champion. This boxing pro is also a cancer survivor. July is Sarcoma and Bone Cancer Awareness Month, so recognizing Daniel’s story now seems fitting. It’s also an opportune time to talk about bone cancer, risk factors, and treatment options. Read on for more details.
New Treatment Options for Relapsed or Refractory Diffuse Large B-Cell Lymphoma
If you or someone you love is facing a diffuse large B-cell lymphoma (DLBCL) diagnosis, and the lymphoma has either relapsed or has not responded to initial treatment, read on to learn about new treatment options that can help.
Advancing the Promise of Precision Medicine
In December 2020, CSC hosted a 3-day virtual summit on the topic of precision medicine. The summit was an action-oriented event focused on eliciting feedback from patients regarding CSC precision medicine education materials and educating the cancer community on the promise of precision medicine and the barriers and gaps that exist in ensuring access for all.
For Cancer Patients, Treatment Decisions Involve a Heavy Dose of Consideration
When it comes to treatment decisions, many cancer patients are worried about more than just treating the cancer. CSC’s Research and Training Institute asked patients to share their perspectives on this in two different research studies, and the findings highlighted that when it comes to deciding which cancer treatment to pursue, there’s a lot to consider.
Biomarker Testing Tool Empowers Lung Cancer Patients
The Cancer Support Community is excited to announce the launch of its new Biomarker Testing Tool for lung cancer. This groundbreaking streamlined platform empowers lung cancer patients and their loved ones to be informed and active participants in the treatment decision-making process.